These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 18316602

  • 1. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, Breier G.
    Cancer Res; 2008 Mar 01; 68(5):1388-97. PubMed ID: 18316602
    [Abstract] [Full Text] [Related]

  • 2. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H, Stephens LC, Kumar R.
    Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771
    [Abstract] [Full Text] [Related]

  • 3. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P.
    Cancer Res; 2006 Feb 15; 66(4):2202-9. PubMed ID: 16489022
    [Abstract] [Full Text] [Related]

  • 4. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T, Miyazono K.
    Cancer Res; 2009 Apr 01; 69(7):2783-91. PubMed ID: 19293183
    [Abstract] [Full Text] [Related]

  • 5. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE, Cantin C, Nantel A, Wang E, Durocher Y, Banville M, Paul-Roc B, Marcil A, Wilson MR, O'Connor-McCourt MD.
    Oncogene; 2010 Feb 11; 29(6):831-44. PubMed ID: 19935703
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of HER2-induced endothelial cell retraction.
    Carter WB, Niu G, Ward MD, Small G, Hahn JE, Muffly BJ.
    Ann Surg Oncol; 2007 Oct 11; 14(10):2971-8. PubMed ID: 17593333
    [Abstract] [Full Text] [Related]

  • 7. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, Mikulits W.
    Oncogene; 2006 May 25; 25(22):3170-85. PubMed ID: 16607286
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.
    Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, Balmain A.
    Cell Growth Differ; 1998 May 25; 9(5):393-404. PubMed ID: 9607560
    [Abstract] [Full Text] [Related]

  • 9. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.
    Rezaei M, Friedrich K, Wielockx B, Kuzmanov A, Kettelhake A, Labelle M, Schnittler H, Baretton G, Breier G.
    Breast Cancer Res; 2012 Dec 06; 14(6):R154. PubMed ID: 23216791
    [Abstract] [Full Text] [Related]

  • 10. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
    Yamaoka-Tojo M, Tojo T, Kim HW, Hilenski L, Patrushev NA, Zhang L, Fukai T, Ushio-Fukai M.
    Arterioscler Thromb Vasc Biol; 2006 Sep 06; 26(9):1991-7. PubMed ID: 16763158
    [Abstract] [Full Text] [Related]

  • 11. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
    Weeks BH, He W, Olson KL, Wang XJ.
    Cancer Res; 2001 Oct 15; 61(20):7435-43. PubMed ID: 11606377
    [Abstract] [Full Text] [Related]

  • 12. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.
    Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771
    [Abstract] [Full Text] [Related]

  • 13. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 14. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family.
    Vrana JA, Stang MT, Grande JP, Getz MJ.
    Cancer Res; 1996 Nov 01; 56(21):5063-70. PubMed ID: 8895765
    [Abstract] [Full Text] [Related]

  • 15. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z.
    Clin Cancer Res; 2007 Oct 01; 13(19):5692-702. PubMed ID: 17908958
    [Abstract] [Full Text] [Related]

  • 16. Angiogenesis: the VE-cadherin switch.
    Wallez Y, Vilgrain I, Huber P.
    Trends Cardiovasc Med; 2006 Feb 01; 16(2):55-9. PubMed ID: 16473763
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL.
    Cancer Res; 2008 Mar 15; 68(6):1809-19. PubMed ID: 18339861
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, Muiru GT, Murphy A, Higgins LS, Chakravarty S, Wong DH.
    Mol Pharmacol; 2007 Jul 15; 72(1):152-61. PubMed ID: 17400764
    [Abstract] [Full Text] [Related]

  • 19. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.
    Gastroenterology; 2009 Jul 15; 137(1):165-75. PubMed ID: 19328798
    [Abstract] [Full Text] [Related]

  • 20. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells.
    Maschler S, Grunert S, Danielopol A, Beug H, Wirl G.
    Oncogene; 2004 Apr 29; 23(20):3622-33. PubMed ID: 15116096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.